Precision Quantomics, an LSW Institute WIN Venture, Awarded NIH Grant to Develop Recombinant Human Enzyme Kits

Precision Quantomics, a leader in proteomics and quantitative systems pharmacology, has received a new NIH award to develop recombinant human enzyme kits that advance personalized medicine and drug metabolism research. Building on a prior NIH STTR grant, the project addresses genetic variability in drug metabolism, particularly among underrepresented US patient populations.